$9.8675
0[0.00%]
Last update: 3:00PM Get Real Time Here
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
02/07/2023 | SNPHY | Santen Pharmaceutical | FY | 2022 | $0.56 | $0.56 | — | $1.93B | $1.93B | — | Get Alert |
11/08/2022 | SNPHY | Santen Pharmaceutical | FY | 2022 | — | — | — | $2.03B | $2.03B | — | Get Alert |
08/04/2022 | SNPHY | Santen Pharmaceutical | FY | 2022 | — | — | — | $2.04B | $2.04B | — | Get Alert |
02/10/2022 | SNPHY | Santen Pharmaceutical | FY | 2021 | $0.94 | $0.94 | — | $2.48B | $2.48B | — | Get Alert |
08/06/2021 | SNPHY | Santen Pharmaceutical | FY | 2021 | $0.94 | $0.94 | — | $2.48B | $2.48B | — | Get Alert |
02/04/2020 | SNPHY | Santen Pharmaceutical | FY | 2020 | $0.88 | $0.88 | — | $2.28B | $2.28B | — | Get Alert |
11/07/2019 | SNPHY | Santen Pharmaceutical | FY | 2020 | $0.88 | $0.88 | — | $2.28B | $2.28B | — | Get Alert |
There have been no specific sales or earnings guidance reported for Santen Pharmaceutical in recent months.
Browse guidance and forecast on all stocks.